Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Tumblr

- PMLiVE

How to choose your social media platform

One of the most important factors to consider is the localisation of your audience

- PMLiVE

Healthcare is long overdue for a digital revolution, says Doximity

US social network for doctors reaches 100,000 members

New data backs Pfizer’s Eliquis in atrial fibrillation

Findings bode well for the drug's commercial prospects

- PMLiVE

India revokes Pfizer’s patent on Sutent

Loses patent protection for kidney cancer drug after Cipla and Natco challenge

Shionogi-ViiV to file HIV drug dolutegravir for approval

GSK, Pfizer and Shionogi joint venture completes phase III trials programme

Social media trails behind online articles, according to health information study

Around 90 per cent of health information consumed by participants came from articles, while 2 per cent was received via social media

- PMLiVE

RCGP unveils draft Social Media Highway Code for doctors

Offers UK healthcare professionals 10 guiding principles to follow

- PMLiVE

AZ launches science blog LabTalk

Hopes new blog will build relationships with potential collaborators

FDA sets new date for Eliquis review in atrial fibrillation

US regulator had asked for more data from Pfizer and BMS

- PMLiVE

Online education campaign results spell success for Doctors.net.uk

Over 6,000 GPs visited The Royal Marsden online educational site

Pfizer calls on pharmacists to promote medicine adherence

Unused medicines cost NHS England £300m per year

- PMLiVE

Pfizer’s RA drug tofacitinib tops methotrexate in phase III

Trial results back drug as major new treatment in rheumatoid arthritis

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links